MicroStrategy Incorporated

Defiance Daily Target 1.75X Long MSTR ETF

Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. The firm's lead program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF, is being developed for the treatment of autoimmune pulmonary alveolar proteinosis. The company was founded in December 1995 and is headquartered in Austin, TX.

MSTX seeks to provide 2x leveraged exposure to the daily share price movement of the MicroStrategy Incorporated (NYSE: MSTR), less fees and expenses.

MSTX, a leveraged ETF tied to MicroStrategy and Bitcoin, offers high potential returns but carries significant risk due to leverage and BTC volatility. Trump's pro-crypto stance and Bernstein's $200k BTC forecast support a bullish outlook for MSTX, despite inherent risks. MSTX's leveraged returns align with its goal, but volatility decay and non-diversification elevate risks, making it suitable for momentum traders.

MSTX: Take The Risk, Make The Gains

T-Rex 2X Long MSTR Daily Target ETF

MicroStrategy stock price continued its strong rally, reaching its all-time high of $503 this week. MSTR has been one of the best-performing companies in Wall Street as it jumped by over 830% in the last 12 months, bringing its market cap to over $87 billion.

Avoid MicroStrategy stock: buy MSTU and MSTX ETFs instead

GraniteShares 1.5x Long COIN Daily ETF

Direxion Daily Nvda Bull 2X Shares

GraniteShares 2x Long PLTR Daily ETF

T-Rex 2X Long Tesla Daily Target ETF

While the rally was broad-based, a few stocks soared in anticipation of the so-called Trump trade, making single-stock ETFs winners last week.

Single-Stock ETFs Dominate the Best Week's Rally of 2024

AXS TSLA Bear Daily ETF

GraniteShares 2x Long UBER Daily ETF

These single-stock inverse/leveraged ETFs ruled last week.

5 Single Stock Inverse/Leveraged ETFs That Ruled Last Week

MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs, a leading provider of thematic and leverage-focused exchange-traded funds, is thrilled to announce that its MSTX ETF (1.75X MicroStrategy ETF) has surpassed $300 million in assets under management (AUM).

MSTX, The First Leveraged MicroStrategy ETF in the U.S. Surpasses $300 Million

MIAMI, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs, a leading provider of thematic and leverage-focused exchange-traded funds, is thrilled to announce that its MSTX ETF (1.75X MicroStrategy ETF) has surpassed $200 million in assets under management (AUM).

MSTX, The First Leveraged MicroStrategy ETF in the U.S. Surpasses $200 Million

NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs, a leading provider of leverage-focused exchange-traded funds (ETFs), has filed with the SEC to increase the leverage exposure on its flagship MSTX (MicroStrategy) ETF from 1.75x to 2x.

Defiance ETFs Files to Increase Leverage on MSTX (MicroStrategy) ETF from 1.75x to 2x, Surpassing $100 Million in Assets

MIAMI, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Defiance ETFs is proud to unveil MSTX, the first single-stock long leveraged ETF for MicroStrategy. MSTX seeks to provide 175% long daily targeted exposure to MicroStrategy.

News for Defiance Daily Target 1.75X Long MSTR ETF ETF (MSTX)